<?xml version="1.0" encoding="UTF-8"?>
<p>The world is facing a major public health crisis due to the pandemic caused by a recently-described coronavirus, named SARS-CoV-2 
 <xref rid="B01" ref-type="bibr"/>
 <xref rid="B02" ref-type="bibr"/>
 <xref rid="B03" ref-type="bibr">1-3</xref>. Reaching proportions that far surpass those of SARS and MERS, the SARS-CoV-2 epidemic started in Wuhan, China in December 2019, but has now spread to more than 130 countries worldwide and has infected approximately 142,000 people, with more than 5,000 deaths being attributed to it (WHO, March 13
 <sup>th</sup> 2020) 
 <xref rid="B04" ref-type="bibr">4</xref>. Sequencing analysis of the viral genome has revealed mutations in the spike protein—which is essential for SARS-CoV-2 attachment and invasion into host cells—may have favored the spill over from bats to humans 
 <xref rid="B01" ref-type="bibr">1</xref>. Most patients infected with coronaviruses develop a mild flu-like disease, in which the most common symptoms are fever and cough. However, in a study of 1,099 patients from 552 hospitals from 30 provinces of China in 2020, Guan W et al. 
 <xref rid="B05" ref-type="bibr">5</xref>, revealed that 15.7% of the patients who develop severe disease have increased difficulty in breathing because of pneumonia. Radiological imaging of the lungs revealed opacity in 56.4% of the patients. Approximately 2.7% of the patients needed assisted ventilation, and 1.4% died 
 <xref rid="B01" ref-type="bibr">1</xref>.
</p>
